Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
HR ›
HRA PHARMA DREAM - DARE - SHARE
Trademark search for:
HRA PHARMA DREAM - DARE - SHARE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-09-28 — Application filed
2016-03-31 — Sn assigned for sect 66a appl from ib
2016-04-06 — Application filed
2016-04-06 — Assigned to examiner
2016-04-11 — Final disposition recorded
2016-04-12 — Application filed
2016-04-12 — Office action issued
2016-04-12 — Office action issued
2016-04-12 — Office action issued
2016-04-13 — Application filed
2016-05-14 — Office action issued
2016-11-08 — Application abandoned
2016-11-08 — Application abandoned
2016-11-08 — Final status recorded
2017-08-30 — Notification of possible opposition created, to be sent to ib
2017-08-30 — Notification of possible opposition sent to ib
2017-09-15 — Notification of possible opposition - processed by ib
2017-11-08 — Final disposition recorded
2017-11-08 — Final disposition recorded
2017-11-24 — Final disposition recorded
2021-02-05 — New representative at ib received
2021-05-14 — Change of name/address rec'd from ib
2023-02-04 — New representative at ib received
2023-03-11 — New representative at ib received
2024-05-19 — New representative at ib received
2025-01-03 — New representative at ib received
Owner Information
LABORATOIRE HRA PHARMA
FR
Correspondent
Association MONOD AMAR BOUDRANT, Maître Stephen MONOD, Avocat 21 rue Monsieur F-75007 PARIS, FRANCE
Filing Details
Filing Date:
2015-09-28
Status Date:
2016-11-08
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.